Abstract:AIMS: The study aimed to investigate the value of autoantibodies in predicting the risk of ketoacidosis or microalbuminuria in children with type 1 diabetes mellitus.METHODS: Clinical data and laboratory indicators of 80 patients with type 1 diabetes admitted to the Department of Endocrinology in Tianjin Children's Hospital, from June 2017 to March 2019, were retrospectively analyzed. The patients were divided into two groups: diabetes without ketoacidosis group (n = 20) and diabetes with ketoacidosis group (n = 60). The differences in general data, laboratory test indexes, and autoantibodies between the two groups were analyzed. Finally, ROC curves and multivariate logistic regression analysis were used to explore the value of autoantibodies in patients with ketoacidosis or microalbuminuria.RESULTS: A total of 80 children with type 1 diabetes were assessed, including 35 boys and 45 girls, ranging in age from 10 months to 15 years. The concentration of GADA, IA2A, and ZnT8A was not statistically different between the two groups, but the positive rate of ZnT8A was statistically significant (p = 0.038) and had a diagnostic value for the occurrence of ketoacidosis (p = 0.025). ZnT8A-positive patients had a higher titer of IA2A and a more frequent prevalence of GADA and IA2A than ZnT8A-negative patients (p < 0.01). In multivariate logistic regression analyses, the presence of positive ZnT8A was associated with a higher risk of microalbuminuria independent of age, sex, and BMI (OR = 4.184 [95% CI 1.034~16.934], p = 0.045).CONCLUSIONS: The positive ZnT8A had diagnostic value for ketoacidosis in children with type 1 diabetes and had the highest specificity among the three kinds of autoantibodies. Moreover, ZnT8A positivity was related to a higher titer of IA2A and more frequent occurrence of multiple diabetes-related autoantibodies. Besides, the presence of positive ZnT8A was an independent risk factor of microalbuminuria in children with type 1 diabetes. Therefore, we can infer that positive ZnT8A may be related to ketoacidosis and microalbuminuria, accelerating the progression of T1DM.

Zinc transporter 8 and its autoantibody

Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus

Update on the ZNT8 epitope and its role in the pathogenesis of type 1 diabetes

Evaluating the Diagnostic Accuracy of Anti- Zinc Transporter 8 Antibodies in Type 1 Diabetes: A Systematic Review and Meta-Analysis

[Expression of Zinc Transporter 8 in Saccharomyces Cerevisiae and Its Antigenicity Analysis].

Beta cell specific ZnT8 gene deficiency and resulting loss in zinc content significantly improve insulin secretion

Prevalence, diagnostic utility, and clinical characteristics of ZnT8 antibody in children with type 1 diabetes in Northern Taiwan

Screening and identification of human ZnT8-specific single-chain variable fragment (scFv) from type 1 diabetes phage display library

Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice

Pancreatic β cell–selective zinc transporter 8 insufficiency accelerates diabetes associated with islet amyloidosis

Interactions between Zinc Transporter-8 Gene ( SLC 30 A 8 ) and Plasma Zinc Concentrations for Impaired Glucose Regulation and Type 2 Diabetes Running title : Zinc-SLC 30 A 8 Interaction for T 2 D

Lack of ZnT8 protects pancreatic islets from hypoxia- and cytokine-induced cell death

Deficiency of ZnT8 Promotes Adiposity and Metabolic Dysfunction by Increasing Peripheral Serotonin Production.

Interactions Between Zinc Transporter-8 Gene (SLC30A8) and Plasma Zinc Concentrations for Impaired Glucose Regulation and Type 2 Diabetes.

Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese.

Clinical study of autoantibodies in type 1 diabetes mellitus children with ketoacidosis or microalbuminuria

The Zinc Transporter Slc39a5 Controls Glucose Sensing and Insulin Secretion in Pancreatic Β-Cells Via Sirt1- and Pgc-1α-mediated Regulation of Glut2

Targeting the Zinc Transporter ZIP7 in the Treatment of Insulin Resistance and Type 2 Diabetes

Pathogenic Mechanism of Autoimmune Diabetes Mellitus in Humans: Potential Role of Streptozotocin-Induced Selective Autoimmunity against Human Islet β-Cells

[Etiological Dissection in Common Anti-Islet Autoantibody-Negative Patients with Type 1 Diabetes].

Screening of Diabetes-Associated Autoantigens and Serum Antibody Profiles by Phage Display System